190 related articles for article (PubMed ID: 17545600)
1. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.
Singh PK; Wen Y; Swanson BJ; Shanmugam K; Kazlauskas A; Cerny RL; Gendler SJ; Hollingsworth MA
Cancer Res; 2007 Jun; 67(11):5201-10. PubMed ID: 17545600
[TBL] [Abstract][Full Text] [Related]
2. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
4. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D
Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055
[TBL] [Abstract][Full Text] [Related]
5. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
6. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion.
Swanson BJ; McDermott KM; Singh PK; Eggers JP; Crocker PR; Hollingsworth MA
Cancer Res; 2007 Nov; 67(21):10222-9. PubMed ID: 17974963
[TBL] [Abstract][Full Text] [Related]
7. Cell surface-associated mucins in signal transduction.
Singh PK; Hollingsworth MA
Trends Cell Biol; 2006 Sep; 16(9):467-76. PubMed ID: 16904320
[TBL] [Abstract][Full Text] [Related]
8. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
9. MUC1 tyrosine phosphorylation activates the extracellular signal-regulated kinase.
Wang H; Lillehoj EP; Kim KC
Biochem Biophys Res Commun; 2004 Aug; 321(2):448-54. PubMed ID: 15358196
[TBL] [Abstract][Full Text] [Related]
10. Cell signaling through membrane mucins.
Carraway KL; Ramsauer VP; Haq B; Carothers Carraway CA
Bioessays; 2003 Jan; 25(1):66-71. PubMed ID: 12508284
[TBL] [Abstract][Full Text] [Related]
11. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
12. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma.
MacMillan-Crow LA; Greendorfer JS; Vickers SM; Thompson JA
Arch Biochem Biophys; 2000 May; 377(2):350-6. PubMed ID: 10845713
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
16. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase.
Mariette C; Piessen G; Leteurtre E; Hémon B; Triboulet JP; Van Seuningen I
Surgery; 2008 Jan; 143(1):58-71. PubMed ID: 18154934
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.
Merlin J; Stechly L; de Beaucé S; Monté D; Leteurtre E; van Seuningen I; Huet G; Pigny P
Oncogene; 2011 Jun; 30(22):2514-25. PubMed ID: 21258405
[TBL] [Abstract][Full Text] [Related]
19. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
20. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
